Atogepant just met a late-stage study goal. Researchers say the results could help prevent an all-too-common condition that impacts millions of women.

Source: [Inc.](https://www.inc.com/lucia-auerbach/migraine-condition-affects-1-in-3-women-treatment-just-met-a-phase-3-goal/91407158)

Sponsored